First Capital Advisors Group’s Integra LifeSciences IART Stock Holding History

First Capital Advisors Group’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$946	Buy	+23	New	+$1.11K	﹤0.01%	876
2018 Q2	–	Sell	-736	Closed	-$41K	–	430
2018 Q1	$41K	Buy	+736	New	+$38.6K	0.02%	300

Other funds holding IART

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

First Capital Advisors Group's IART Position: Q2 2023 in Review

First Capital Advisors Group opened a new position in Integra LifeSciences (IART) in Q2 2023: 23 shares worth $946. The stake represents ﹤0.01% of the portfolio and ranks #876 among its holdings. This is a return to the name: First Capital Advisors Group previously reported a position in IART as recently as Q1 2018.

First Capital Advisors Group first reported a position in IART in Q1 2018 and has held it in 2 quarters since. The position peaked at $41K in Q1 2018. 283 funds tracked by Wall St. Rank hold IART as of Q2 2023.

First Capital Advisors Group held 23 shares of Integra LifeSciences worth $946 as of Q2 2023.
Integra LifeSciences was a new First Capital Advisors Group position in Q2 2023.
Integra LifeSciences made up ﹤0.01% of First Capital Advisors Group's portfolio in Q2 2023, its #876 holding.
First Capital Advisors Group first reported a position in Integra LifeSciences in Q1 2018 and has held it in 2 quarters since.
First Capital Advisors Group's Integra LifeSciences position peaked at $41K in Q1 2018.
283 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2023.

Based on First Capital Advisors Group's 13F filing for Q2 2023, filed 15 Aug 2023.